Metformin may protect nondiabetic breast cancer women from metastasis (Q46244897)

20 December 2017

title

Metformin may protect nondiabetic breast cancer women from metastasis (English)

1 reference

20 December 2017

1 reference

Sahar Mohammed El-Haggar

1

1 reference

20 December 2017

Nagla A El-Shitany

2

1 reference

20 December 2017

Mohamed Farouk Mostafa

3

1 reference

20 December 2017

Noha Ahmed El-Bassiouny

4

1 reference

20 December 2017

publication date

22 February 2016

1 reference

20 December 2017

Clinical & Experimental Metastasis

published in

1 reference

20 December 2017

volume

33

1 reference

20 December 2017

issue

4

1 reference

20 December 2017

page(s)

339-357

1 reference

20 December 2017

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

cites work

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Crystal structure of human insulin-like growth factor-1: detergent binding inhibits binding protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

The role of the IGF system in cancer: from basic to clinical studies and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Insulin-Dependent Regulation of Insulin-Like Growth Factor-Binding Protein-1*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Type 2 diabetes mellitus, glycemic control, and cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Diabetes and cancer: a consensus report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Associations of insulin resistance and adiponectin with mortality in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Insulin and insulin-like growth factor signalling in neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Metformin and cancer: new applications for an old drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Metformin and reduced risk of cancer in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Effects of metformin on breast cancer cell proliferation, the AMPK pathway and the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Metformin intervention in obese non-diabetic patients with breast cancer: phase II randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Is it time to test metformin in breast cancer clinical trials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Risk Factors of Vitamin B12 Deficiency in Patients Receiving Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Determination of Glucose in Blood Using Glucose Oxidase with an Alternative Oxygen Acceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

The role of the IGF system in cancer growth and metastasis: overview and recent insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Differential interactions between IGFBP-3 and transforming growth factor-beta (TGF-beta) in normal vs cancerous breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Effects of metformin on endometrial cancer cell growth in vivo: a preoperative prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Metformin therapy increases insulin-like growth factor binding protein-1 in hyperinsulinemic women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Role of the insulin-like growth factor family in cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

IGF and insulin receptor signaling in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Characterization of multiple signaling pathways of insulin in the regulation of vascular endothelial growth factor expression in vascular cells and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Elevated insulin receptor content in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Understanding the Warburg effect: the metabolic requirements of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Increase of O-glycosylated oncofetal fibronectin in high glucose-induced epithelial-mesenchymal transition of cultured human epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Effects of different doses of metformin treatment for 6 months on aberrant crypt foci in Chinese patients with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Five or more years of adjuvant endocrine therapy in breast cancer: a meta-analysis of published randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

IGF status is altered by tamoxifen in patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Metformin induces unique biological and molecular responses in triple negative breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Effect of metformin and adriamycin on transplantable tumor model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Antihyperglycaemic therapies and cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Metformin inhibits epithelial-mesenchymal transition in prostate cancer cells: involvement of the tumor suppressor miR30a and its target gene SOX4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S10585-016-9782-1

Evaluation of endocrine changes in women with the polycystic ovary syndrome during metformin treatment

21 January 2018

1 reference

12 December 2020

Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer

1 reference

12 December 2020

Changes in serum IGF-1 level and tumor VEGF expression in mice with colorectal cancer under hyperglycemic conditions

1 reference

12 December 2020

Insulin-like Growth Factor Binding Protein-3 Induces Apoptosis in MCF7 Breast Cancer Cells

1 reference

12 December 2020

Effect of metformin on insulin-like growth factor (IGF) I and IGF-binding protein I in polycystic ovary syndrome.

1 reference

12 December 2020

Cisplatin combined with metformin inhibits migration and invasion of human nasopharyngeal carcinoma cells by regulating E-cadherin and MMP-9.

1 reference

12 December 2020

Insulin-like growth factor (IGF)-1, IGF-binding protein-3, and pancreatic cancer in male smokers.

1 reference

12 December 2020

Effect of metformin on apoptosis, cell cycle arrest migration and invasion of A498 cells

1 reference

12 December 2020

Expression and clinical significance of IGF-1, IGFBP-3, and IGFBP-7 in serum and lung cancer tissues from patients with non-small cell lung cancer

1 reference

12 December 2020

Epithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor-binding protein 3?

1 reference

12 December 2020

Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling

1 reference

12 December 2020

[Effect of metformin addition to an acute lymphoblastic leukemia chemotherapy treatment].

1 reference

12 December 2020

10.1007/S10585-016-9782-1

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017